Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Oct 12;17(3):330–340. doi: 10.1016/j.bbmt.2010.09.020

Table 1.

Statistical comparison between groups from Figure 1

Groups compared MST (days) and survival rate (%) P value
DL vs. MMB3.19 27, 12% vs. 21, 0% < 0.01
GM-MMB3.19 post-BMT + DL vs. DL 26.5, 14.3% vs. 27, 12% NS (0.8)
GM-MMB3.19 pre-BMT +DL vs. DL 52% vs. 27, 12% < 0.01
GM-MMB3.19 pre-BMT +DL vs. GM-MMB3.19 post-BMT 52% vs. 26.5, 14.3% < 0.01
non-GM-MMB3.19 pre-BMT + DL vs. DL 37.5, 25% vs. 27, 12% = 0.03
GM-MMB3.19 pre-BMT + DL vs. non-GM-MMB3.19 + DL 52% vs. 37.5, 25% = 0.03 (stratified: ≥ 30 days)*
*

Cox-proportional hazards test p < 0.01

Groups were compared using non-parametric Log-Rank test